S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave

The Pennant Group (PNTG) Stock Price, News & Analysis

$20.30
+0.41 (+2.06%)
(As of 04/19/2024 ET)
Today's Range
$19.64
$20.33
50-Day Range
$15.40
$20.72
52-Week Range
$10.31
$20.89
Volume
133,111 shs
Average Volume
119,030 shs
Market Capitalization
$616.92 million
P/E Ratio
46.14
Dividend Yield
N/A
Price Target
$18.75

The Pennant Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
7.6% Downside
$18.75 Price Target
Short Interest
Healthy
1.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$23,697 Sold Last Quarter
Proj. Earnings Growth
17.81%
From $0.73 to $0.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.78 out of 5 stars

Medical Sector

411th out of 911 stocks

Health Services Industry

4th out of 10 stocks

PNTG stock logo

About The Pennant Group Stock (NASDAQ:PNTG)

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

PNTG Stock Price History

PNTG Stock News Headlines

PNTG May 2024 17.500 put
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Forecasting The Future: 4 Analyst Projections For Pennant Gr
Should Value Investors Buy The Pennant Group (PNTG) Stock?
See More Headlines
Receive PNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for The Pennant Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
4/20/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:PNTG
Fax
N/A
Employees
5,791
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.75
High Stock Price Target
$22.00
Low Stock Price Target
$14.00
Potential Upside/Downside
-7.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$13.38 million
Pretax Margin
3.59%

Debt

Sales & Book Value

Annual Sales
$544.89 million
Cash Flow
$0.80 per share
Book Value
$4.86 per share

Miscellaneous

Free Float
27,261,000
Market Cap
$616.92 million
Optionable
Optionable
Beta
2.06
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

PNTG Stock Analysis - Frequently Asked Questions

Should I buy or sell The Pennant Group stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for The Pennant Group in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PNTG shares.
View PNTG analyst ratings
or view top-rated stocks.

What is The Pennant Group's stock price target for 2024?

3 Wall Street research analysts have issued 12 month price objectives for The Pennant Group's stock. Their PNTG share price targets range from $14.00 to $22.00. On average, they anticipate the company's stock price to reach $18.75 in the next year. This suggests that the stock has a possible downside of 7.6%.
View analysts price targets for PNTG
or view top-rated stocks among Wall Street analysts.

How have PNTG shares performed in 2024?

The Pennant Group's stock was trading at $13.92 on January 1st, 2024. Since then, PNTG stock has increased by 45.8% and is now trading at $20.30.
View the best growth stocks for 2024 here
.

When is The Pennant Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our PNTG earnings forecast
.

How were The Pennant Group's earnings last quarter?

The Pennant Group, Inc. (NASDAQ:PNTG) released its quarterly earnings data on Wednesday, February, 28th. The company reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by $0.01. The business had revenue of $145.95 million for the quarter, compared to analysts' expectations of $136.79 million. The Pennant Group had a trailing twelve-month return on equity of 12.78% and a net margin of 2.46%. During the same period in the previous year, the business posted $0.15 earnings per share.

What guidance has The Pennant Group issued on next quarter's earnings?

The Pennant Group issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of 0.820-0.910 for the period, compared to the consensus earnings per share estimate of 0.850. The company issued revenue guidance of $596.8 million-$633.7 million, compared to the consensus revenue estimate of $573.5 million.

What other stocks do shareholders of The Pennant Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Pennant Group investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Energy Transfer (ET), Gilead Sciences (GILD), General Mills (GIS), Harley-Davidson (HOG), Helmerich & Payne (HP), International Business Machines (IBM), International Paper (IP) and Kohl's (KSS).

Who are The Pennant Group's major shareholders?

The Pennant Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (4.21%) and Los Angeles Capital Management LLC (0.23%). Insiders that own company stock include Barry M Smith, Brent Guerisoli, Christopher R Christensen, Daniel H Walker, Jennifer Freeman, Joanne Stringfield, John G Nackel and John J Gochnour.
View institutional ownership trends
.

How do I buy shares of The Pennant Group?

Shares of PNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PNTG) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners